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Cellular mechanisms of chlorothiazide and cellular potassium deple-
tion on Mg2 uptake in mouse distal convoluted tubule cells. The use of
the distally-acting diuretic, chlorothiazide, has been reported to have
important effects on renal magnesium handling. The cellular mechanisms
of chlorothiazide action on Mg2 uptake was investigated in immortalized
mouse distal convoluted tubule (MDCT) cells. Intracellular free Mg2
concentration was determined by microfluorescence. Mg2 transport was
measured as a function of change in intracellular Mg2 concentration with
time following placement of Mg2-depleted cells into a buffer containing
1.5 mtvi magnesium. The uptake rate of Mg2 into Mg2tdepleted cells
was 179 28 nM/second. Mg2 uptake was dependent on the membrane
voltage as membrane hyperpolarization enhanced uptake whereas depo-
larization diminished transport. Chlorothiazide increased Mg2 uptake by
58%, from 179 28 to 283 23 nM/second. The ability of chlorothiazide
to stimulate Mg2 uptake in MDCT cells was concentration-dependent
and related to the diuretic-induced hyperpolarization of the plasma
membrane. These studies support the notion that acute chlorothiazide
administration enhances renal magnesium conservation through its effects
on Mg2 transport within the distal convoluted tubule. Since chronic
chlorothiazide administration may result in hypokalemia as well as
hypomagnesemia, Mg2 uptake was determined in potassium-depleted
MDCT cells. Mg2 uptake was diminished, 80 24 nM/second, in
potassium depleted cells. Hyperpolarization of the plasma membrane with
the cell permanent anion, SCN, corrected Mg2 uptake in potassium
depleted cells suggesting that the basis for diminished uptake may, in part,
be due to depolarization of the membrane voltage. In summary, acute
chlorothiazide stimulates Mg2 transport in MDCT cells. We postulate
that chronic chlorothiazide use may lead to hypokalemia that in turn
diminishes Mg2 transport in the distal tubule resulting in urinary
magnesium-wasting.
The pattern of segmental magnesium reabsorption in the
kidney is distinct from other ions such as sodium or calcium.
Unlike sodium or calcium, little magnesium is reabsorbed in the
proximal tubule (about 15% of the glomerular filtrate). Most of
the filtered magnesium (60 to 70%) is reabsorbed in the thick
ascending limb of the loop of Henle [1]. Some 5 to 10% of the
filtered magnesium is reabsorhed in the distal convoluted tubule,
whereas there is little or no reabsorption in the collecting system
[1]. Accordingly, the distal convoluted tubule plays an important
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role in controlling the final amount of magnesium appearing in
the urine. Although the distal convoluted tubule reabsorbs only 5
to 10% of the filtered magnesium, this is 60 to 70% of the load
delivered to it from the loop of Henle [2, 3]. Magnesium
reabsorption within the distal tubule is influenced by a number of
hormonal and diuretic factors but the cellular mechanisms of
these influences are not known [4—7].
Thiazides have been used extensively in clinical medicine
because of their diuretic and anticalciuretic effects. Thiazides,
through their actions on the Na-CY cotransporter, inhibit
sodium chloride reabsorption in the distal convoluted tubule
leading to an increase in urinary sodium excretion [8]. Thiazides
have also been shown to stimulate calcium reabsorption resulting
in diminished urinary calcium excretion [9—111. The increased
sodium excretion and enhanced calcium reabsorption provide the
basis for the wide-spread use of thiazides in clinical medicine.
The effects of thiazides on renal magnesium handling are
controversial [12, 131. Acute studies performed on experimental
animals indicate that chlorothiazide has little or no effect on
urinary magnesium excretion whereas sodium excretion is mark-
edly increased and calcium excretion rises modestly [14—171. In
these studies, chlorothiazide was given acutely to experimental
animals and resulted in significant decreases in urinary magne-
sium and calcium excretions relative to the natriuretic responses
lending credence to the notion that thiazides enhance magnesium
as well as calcium reabsorption. These conclusions are in contrast
to the chronic observations reporting the effects of long-term
thiazide treatment in patients. Although there are a few reports of
little or no effect of thiazides on renal magnesium handling [10,
13, 18, 19], the majority of clinical studies indicate that chronic
thiazide use may lead to renal magnesium-wasting predisposing
patients to hypomagnesemia [20—26]. On balance, these observa-
tions suggest that acute administration of chiorothiazide results in
renal magnesium conservation, whereas long-term usage may lead
to an increase in urinary magnesium excretion. The cellular
actions of chlorothiazide on magnesium transport within the distal
tubule are not known.
Chronic administration of chlorothiazide to humans or experi-
mental animals by depleting extracellular fluid volume leads to
elevated renin-angiotensin, aldosterone, and enhanced distal so-
dium reabsorption. This also increases distal potassium secretion
which may result in hypokalemia. Potassium depletion has been
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reported to increase urinary divalent cation excretion [27—301.
Accordingly, chiorothiazide-induced cellular potassium depletion
may underlie the changes in altered renal magnesium handling
with long-term use of thiazides [3 1—331.
The present studies were designed to elucidate some of the
mechanisms of cellular magnesium transport in the distal convo-
luted tubule. Microfluorescent studies were used to determine
intracellular free Mg2 in normal and Mg2 *depleted immortal-
ized mouse distal convoluted tubule (MDCT) cells. The Mg2-
depleted MDCT cells were placed in a high Mg2 medium and
the refilling rate of intracellular Mg2 was measured as a function
of time [34]. Mg2 uptake is selective for magnesium and
influenced by the transmembrane voltage. Moreover, the influx
rate is rapid and reproducible so that it is possible to determine
the effect of physiological influences on transport rates. In the
present study, this approach was used to show that chlorothiazide
stimulates Mg2 uptake into MDCT cells. Further studies suggest
that chiorothiazide acts through changes in the membrane voltage
of the plasma membrane to alter Mg2 transport. These data
provide the basis for the reports concerning the acute affects of
chiorothiazide. As long-term usage of thiazides may lead to
hypokalemia and hypermagnesiuria, we determined the effect of
cellular potassium-depletion on Mg2 uptake in MDCT cells.
Mg2 uptake into potassium-depleted MDCT cells was dimin-
ished relative to normal cells. These findings are supportive of the
notion that chronic thiazide administration may lead to dimin-
ished renal magnesium reabsorption and increased urinary excre-
tion through its well known effects on potassium conservation.
Methods
Materials
Basal Dulbecco's minimal essential medium (DMEM) and
Ham's F-12 media were purchased from GIBCO. Customized
magnesium-free and potassium-free media were purchased from
Stem Cell Technologies Inc. (Vancouver, BC, Canada). Fetal calf
serum was from Flow Laboratories (McLean, VA, USA). Mag-
fura-2/AM, fura-2/AM, PBFI/AM, and DiOC( [31/AM were ob-
tained from Molecular Probes (Eugene, OR, USA). All other
materials were from Sigma Chemical Co. (St. Louis, MO, USA).
Cell culture
Distal convoluted tubule cells were isolated from mice, immor-
talized, and characterized as previously described [35, 36]. The
MDCT cell line was grown on 60 mm plastic culture dishes
(Corning Glass Works, Corning Medical and Scientific, Corning,
NY, USA) in DMEM/Ham's F-12, 1:1, media supplemented with
10% fetal calf serum, 1 mrvi glucose, 5 ms L-glutamine, 50 U/mI
penicillin, and 50 g/ml streptomycin in a humidified environment
of 5% CO2-95% air at 37°C. For the fluorescent studies, confluent
cells were washed three times with phosphate-buffered saline
(PBS) containing 5 mrvt ethylene glycol-bis(-aminoenylyl eth-
er)N,N,N',N'-tetraacetic acid (EGTA), trypsinized, and seeded
on glass cover slips. Aliquots of harvested cells were allowed to
settle onto sterile glass cover slips in 100-mm Corning tissue
culture dishes, and the cells were grown to subconfluence over one
to two days in supplemented media as described above. The
normal media contained 0.6 mrvi Mg2 and 4.8 m'vi K. In the
experiments indicated, the cells were cultured in Mg2-free media
(<0.01 mM) or Mg2-free, low K containing 2.5 m KC1 at the
concentrations indicated for 8 to 16 hours prior to study. Other
constituents of the Mg2-free and Mg-free, low K media were
similar to the complete media.
Cytoplasmic Mg2 and Ca2 measurements
Cover slips were mounted into a perfusion chamber, and
[Mg2]1 and [Ca2], determined with the use of the Mg2-
sensitive and Ca2-sensitive fluorescent dyes mag-fura-2 and
fura-2, respectively. The cell-permeant acetoxymethyl ester (AM)
form of the dye was dissolved in dimethyl sulfoxide (DMSO) to a
stock concentration of 5 m and then diluted to 5 iM mag-fura-
2/AM or 10 fLM fura-2/AM in media for 20 minutes at 37°C. Cells
were subsequently washed three times with buffered salt solution
containing (in mM) 145 NaCl, 4.0 KC1, 0.8 Na2HPO4, 0.2
KH2PO4, 1.0 CaCl2, 5 glucose, and 20 N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid (HEPES)/tris (hydroxymethyl) ami-
nomethane (Tris), at pH 7.4. The MDCT cells were incubated for
a further 20 minutes to allow for complete deesterfication and
washed once before measurement of fluorescence.
Epifluorescence microscopy was used to monitor changes in the
mag-fura-2 or fura-2 fluorescence of the MDCT cell monolayer.
The chamber was mounted on an inverted Nikon Diaphot-TMD
microscope, with a Fluor —100 objective, and fluorescence was
monitored under oil immersion within a single cell over the course
of study. Fluorescence was recorded at 1 second intervals using a
dual-excitation wavelength spectrofluorometer (Delta-scan, Pho-
ton Technologies, Princeton, NJ, USA) with excitation for mag-
fura-2 at 335 and 385 nm, for fura-2 at 340 and 380 nm (chopper
speed set at 100 Hz/s), and emission at 505 nm. All experiments
were performed at 21°C, since the mag-fura-2 and fura-2 re-
sponses were found to be identical at room temperature and 37°C.
Media changes were made without an interruption in recording.
The free [Mg2]1 and intracellular Ca2 concentrations
([Ca2]) were calculated from the ratio of the fluorescence at the
two excitation wavelengths as described using a dissociation
constant (I(d) of 1.4 m and 224 nvi, respectively, for the
mag-fura-2 Mg2 and fura-2 Ca2 complexes [37]. The mini-
mum (Rmin) and maximum (Rmax) ratios were determined for the
cells at the end of each experiment using 20 jiM digitonin. Rm ftM
mag-fura-2 was found by the addition of 50 ms MgCl2 in the
absence of Ca2, and Rmjn was obtained by removal of Mg2 and
addition of 100.0 mvt EDTA, pH 7.2. The excitation spectrum of
the cellular mag-fura-2 under these conditions was similar to that
of free mag-fura-2 in the same solutions. Rmax and for fura-2
were obtained with Ca2 and EGTA by previously published
techniques [34].
('ytoplasmic K measurements
Intracellular K concentration ([K]1) was determined by use
of the K -sensitive dye, potassium-binding benzofuran isophtha-
late (PBFI). The cells were loaded with PBFI from a solution of
5 JiM according to the approach given above for mag-fura-2. The
intracellular dye was excited at 340/380 nm and the emission
measured at 500 nm. PBFI was calibrated within the cell by
clamping [K to known values of extracellular K concentration
using 1 jiM valinomycin and 5 jiM nigericin. K becomes distrib-
uted equally on both sides of the membrane so that a standard
curve can be generated by plotting the fluorescence against [K].
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Transmembrane voltage measurements
Transmembrane voltage was measured with the use of the
voltage-sensitive dye, 3,3'-dihexyloxacarbocyanine iodide (DiOC6
[3]). MDCT cells were cultured on glass cover slips. DiOC6 [3],
5 X i0 i, was added to the buffer solution from a stock
solution, 10 m, in DMSO. The cells were incubated for 60
minutes and washed according to the techniques given above for
mag-fura-2. The intracellular dye was excited at 490 tim and the
emission was measured at 510 nm. The voltage-sensitive dye was
calibrated by altering the transmembrane K gradient by sequen-
tial addition of small volumes of 1 M KCI in the presence of 5 JIM
valinomycin and the transmembrane voltage was calculated from
fluorescent changes using the null-point procedure [37].
Statistical analysis
Representative tracings of fluorescent intensities are given, and
significance was determined by Tukey's analysis of variance. A
probability of P < 0.05 was taken to be statistically significant. All
results are means SE where indicated.
Results
Chlorothiazide stimulates Mg21 influx into MDCT cells
Since there is not an appropriate radioisotope for Mg2 to
directly measure magnesium transport rates, we developed the
following model to assess Mg2 influx into single MDCT cells.
Subconfluent MDCT monolayers were cultured in magnesium-
free medium for 8 to 16 hours. These cells possessed a signifi-
cantly lower and reproducible [Mg2]1, 0.22 0.01 mM, as
indicated in Figure 1. When the Mg2-depleted MDCT cells were
placed in a bathing solution containing 1.5 mivi MgC12, intracel-
lular [Mg2] concentration increased with time and levelled at a
[Mg2]1, 0.52 0.06 mrvt, N = 7which was similar to normal cells,
0.53 0.02 mat, N = 7. The rate of refill, d([Mg2]1)/dt, measured
as the change in [Mg2]1 with time, was 179 28 nM/second, N =
7, as determined over the first 500 seconds following the addition
of magnesium. There was no change in intracellular [Ca2] after
the addition of MgCl2 to the bathing medium in either normal or
Mg2-depleted cTAL cells (data not shown). We have previously
shown that the presence of 10 mat CaCI2 in the bathing solution
failed to inhibit Mg2 uptake into the MDCT cells, nor did
[Ca2] change in Mg2-depleted cells, suggesting that the Mg2
entry pathway is not shared by calcium [341. This was confirmed by
determining isotopic 45Ca2 uptake into Mg2-depleted MDCT
cells to directly measure Ca2 transport [34]. Using microfluores-
cence, it was also shown that Mn2 and La3, but not Cd2,
inhibited Mg2 uptake [34]. Finally, the dihydropyridine channel
blocker, nifedipine, inhibited Mg2 uptake suggesting that this
pathway may be related to the L-type Ca2 channels, although it
appears to have a high selectivity of Mg2 over Ca2 [34].
The addition of chlorothiazide (10—a M) to the refill solution
stimulated Mg2 uptake into MDCT cells (Fig. 2). The rate of
Mg2 uptake, d([Mg2],)/dt, increased from 179 28 to 284 23
nM/second, N = 5, which was an increment of 58% over control
values. Although chlorothiazide did not have any apparent effect
on [Mg2], 0.53 0.02 m and d([Mg2]1)/dt 30 23 nM/second,
N = 3, in cells cultured in normal magnesium media, it may have
altered influx rates, but the methodological approach used here to
assess Mg2 uptake would not have detected the changes in
transport (Fig. 2). Our previous studies indicate that [Mg2]1 is
regulated so that changes in Mg2 at normal [Mg2] are not
observed [38]. The effects of chlorothiazide on Mg2 uptake are
concentration-dependent with maximally observed transport rates
of 280 32 nM/second, N 3, attained with iO at as determined
with the Mg2 refill model (Fig. 3). The concentration of chioro-
thiazide that produces a half-maximal stimulation in Mg2 uptake
is about 20 JIM.
The stimulation of Mg2 uptake with chlorothiazide was inhib-
ited with 5.0 mat Mn2 38 40 nM/second, N = 3, and 5.0 mM
La3' 50 44 nM/second, N = 3, but only modestly by 10.0 mat
Ca2, 217 16 nM/second, N = 3. The inhibitors were added as
chloride salts to the refill buffer solution containing 1.5 mat
MgCl2. Nifedipine, 5 JIM, completely inhibited Mg2 uptake, 8
).6Mg 1.5mM Mg I
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Fig. 1. Measurement of Mg2 uptake into single
subconfluent MDCT cells. [Mg2I1 was determined
with mag-fura-2. Cells were cultured in normal
media ([Mg2}, 0.6 m and [Ca], 1.0 mM) or low
Mg media (<0.01 and 1.0 mat, respectively). The
basal [Mg2] was determined and the cells
subsequently placed in buffer solution containing
MgCI2 concentration (1.5 mM). The buffer
solutions contained (in mM): 145 NaCI, 4.0 KCI,
___________________________________________________________________ 0.8 K2HPO4, 0.2 K1-12P04, 1.0 CaCl2, 5 glucose,
and 10 HEPES/Tris, pH 7.4, with and without 1.5
________________________________________________________________________
mM MgCl. Fluorescence was measured at 1 data
point/s with 25 signal-point averaging and1800 smoothed according to methods previously
reported [37]. Fluorescence tracing is
representative of 7 cells.
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Fig. 3. Concentration-dependence of chiorothiazide stimulation of Mg2
uptake into MDCT cells. Cell preparation and fluorescence determinations
were performed according to techniques given in legend to Figure 2 using
the concentrations of chiorothiazides indicated. The Mg2 refill rate was
calculated as a change in Mg2 concentration with time, d([Mg2]/dt, by
linear regression analysis over the first 500 seconds of fluorescent mea-
surements. Values are means SE for 3 to 5 cells.
22 nM/second, N = 4, in Mg2-depleted cells treated with io El
chiorothiazide.
Dependence of Mg2 uptake on membrane voltage
Mg2 uptake into Mg2-depleted MDCT cells is sensitive to
the transmembrane voltage [341. Depolarization of the plasma
membrane, for example, with the elevation of external K , results
in diminished Mg2 uptake (Fig. 4). Conversely, hyperpolariza-
tion is associated with a stimulation of Mg2 uptake dependent on
the transmembrane voltage gradient. Hyperpolarization, either
with the use of the membrane permeable anion, SCN, or with
Fig. 2. Chlorothiazide stimulates Mg2 influx
into normal and Mg2tdepleted MDCT cells.
The cells were prepared and fluorescence
measurements performed according to
techniques given in legend to Figure 1.
Chiorothiazide (CTZ) at a final concentration
1000 1200 of iO vi was added from a stock solution
where indicated. Tracing is representative of 5
cells.
Fig. 4. Membrane voltage alters Mg2 uptake rates in MDCT cells. Mg2
uptake was determined by fluorescent measurements in Mg2-depleted
cells as given in legend to Fig. 1. The basal [Mg2] was determined and
the MDCT cells placed in buffer solution containing 1.5 mvi MgCI2 (•).
The depolarization solutions (LII) contained 15 and 118 mvi KCI (final
concentration) in isosmotic substitution for NaCI. The hyperpolarization
solutions (0) contained NaSCN at 36, 72.5, 108, 145, in an isoosmotic
substitution for NaCI (these values are from [34]). Membrane voltages
were measured with the voltage-sensitive dye DiOC6 [3]. Values for Mg2
uptake, d([Mg2]1)/dt, are means SE, N = 3 to 10 cells.
the application of the potassium ionophore, valinomycin, results
in a maximal three- to fourfold increase in d([Mg2]1)/dt [34].
These results are illustrated in Figure 4. Accordingly, changes in
transmembrane voltage would be expected to alter Mg2 uptake
rate in MDCT cells.
Next we used the fluorescent voltage indicator, DiOC6 [3] to
determine the effect of chiorothiazide on membrane voltage
across the plasma membrane of MDCT cells. Chlorothiazide,
iO vi, resulted in the hyperpolarization, —77.0 0.7 mV, N =
6, from a resting potential of —65.5 2.0 mV, N = 6 (Table 1).
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Table 1. Effect of chlorothiazide and potassium depletion on
membrance voltage of MDCT cells
N
Membrance voltage
mV
Control 6 —65.5 2.0
Chlorothiazide 6 —77.0 0.7a
K depleted 8 —57.9 1.0
ol 1.5mMMq I
Mg
0 200 400 600 800 1000 1200
Time, seconds
Fig. 5. Intracellular potassium depletion diminishes Mg2 uptake into
Mg2'-depleted MDCT cells. Subconfluent cells were incubated for two
hours in normal media but containing 2.5 mtvi potassium, and subsequently
for 16 hours in media containing 2.5 m potassium and zero magnesium.
The refill experiments shown here in potassium depleted cells were
performed with buffer solution as given in legend to Figure 1, but
containing a final concentration of 2.5 ms potassium. Mg2 uptake in
normal Mg2-depleted cells were formed with an external potassium
concentration of 4.8 mtvi. Fluorescence tracing is representative of 5 cells.
These results are consonant with other fluorescence studies and
with those using microelectrodes [36, 39, 40]. As chlorothiazide
inhibits Na-Cl cotransport leading to cellular hyperpolarization,
we postulate that an alteration of the plasma membrane voltage
may be the basis for the increase in Mg2 transport in the distal
convoluted tubule.
Cellular potassium depletion diminishes Mg2 uptake into
MDCT cells
In order to test the effect of intracellular potassium on Mg2
transport, MDCT cells were potassium-depleted by culturing in
media containing 2.5 m potassium and normal magnesium for
two hours at which time the cells were placed in culture media
containing 2.5 m potassium and zero magnesium. Following 16
hours of incubation, the Mg2 uptake rate, d([Mg2]1)/dt, was
determined with microfluorescence. The intracellular K concen-
tration, [K ], determined with PBFI was 126 6 mrvt, N = 3, in
MDCT cells cultured in normal media (magnesium 0.6 mM,
potassium 4.2 mM), 126 5 mrvi, N = 3, in cells cultured in low
magnesium media (zero magnesium, potassium 4.2 mM) and 89
Control refers to membrance voltage determined in Mg2tdcpleted
MDCT cells. In chlorothiazide, the membrane voltage was measured 5
mm following addition of iO— M chlorothiazide to the external buffer
solution. Values are means SE and N is the number of observations.
Significance, P < 0.05, compared to control values
0.6
0.5
Control
Control K-depletion
240
200
160
Fig. 6. Summaiy of Mg2 uptake into Mg2tdepleted and Mg2 and
potassium-depleted MDCT cells. Mg2 uptake was determined as given in
legend to Figure 5 and the rates calculated as d(Mg2],)/dt over the intial
500 seconds of uptake. Values are means SE for 5 to 10 cells.
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Fig. 7. Stimulation of Mg2 uptake in Mg2tdepleted and potassium de-
pleted MDCT cells by hyperpolarization. MDCT cells were either Mg2t
depleted by culturing in media containing no magnesium or Mg2 and
K-depleted by culturing in media containing zero magnesium and 2.5 mM
KCI for 16 hours. The rate of Mg2 uptake, d([Mg2])/dt, was determined
in the presence of NaSCN at the indicated concentrations. The external
buffer solution contained 1.5 mM MgCI2 and NaSCN at the indicated
concentrations in substitution for NaCl. Symbols are: (—) K-depleted;
(----) control. Values are means SE, N = 3 to 10 cells.
5 mM, N = 5, in cells cultured in low potassium media (zero
magnesium, potassium 2.5 mM). Figure 5 illustrates a representa-
tive fluorescence tracing depicting Mg2 uptake in potassium
depleted and Mg2-depleted cells. The mean uptake rate as
reflected by d([Mg2])/dt was 80 24 nM/second, N = 10, which
is significantly lower than observed in cells with normal intracel-
lular potassium concentrations. The refill rate of Mg2-depleted
cells, [Mg21 0.24 0.02 m, with normal potassium, [K]1 126
6 mM, in the presence of 2.5 mrvi K in the buffer solution was
modestly greater 218 44 nM/second, N = 4, than that observed
in the control experiments, 179 28 nM/second. This is likely due
to hyperpolarization of the membrane voltage. Accordingly, the
diminished Mg2 uptake was not due to low extracellular potas-
sium, but rather required intracellular potassium depletion.
0 40
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We postulate that intracellular potassium depletion may lead to
a depolarization of the plasma membrane that may result in
diminished Mg2 uptake in MDCT cells. Using the voltage-
sensitive dye, DiOC( [3], we determined the potential across the
plasma membrane of control and potassium depleted MDCT cells
(Table 1). The membrane voltage was —65.5 2.0 mV, N = 6, in
Mg2-depleted cells with normal [K], 126 6 mM. This value is
not different from normal MDCT cells not Mg2-depleted. Fol-
lowing potassium depletion, the voltage, —57.9 0.9 mV, N = 8,
was significantly depolarized compared to cells with normal [K111.
Next, we determined whether hyperpolarization may enhance
Mg2 uptake in potassium and Mg2-depleted cells. Substitution
of NaSCN for NaC1 in the buffer stimulated Mg2 uptake to a
similar extent in normal and K depleted cells although the
starting transport rate was significantly lower in the potassium
depleted cells (Fig. 7). Accordingly, Mg2 transport is similarly
affected by the membrane voltage in both normal and potassium-
depleted MDCT cells. These studies suggest that the membrane
voltage may partially provide the basis for diminished Mg2
uptake in potassium depleted MDCT cells.
Discussion
Most of our early knowledge concerning magnesium transport
in the distal tubule has come from micropuncture and microper-
fusion studies of the superficial nephron. Micropuncture studies
showed that significant amounts of magnesium was absorbed in
the distal tubule [2—71. The mammalian distal tubule, located
between the macula densa and the cortical collecting duct, is
comprised of a short post-macula densa segment of thick ascend-
ing limb, the distal convoluted tubule, and the connecting tubule.
These studies describing distal magnesium absorption may well
have included portions of the superficial connecting tubule as well
as the convoluted portion. The distal tubule is morphologically
heterogenous and may have significant regionalization of func-
tion. The early micropuncture and microperfusion studies in the
rat and rabbit distal tubule suggest that there are early and late
segments which have differential sensitivity to thiazides and
amiloride [8, 11, 41—43]. Other studies indicate that thiazide-
sensitive Na-Cl cotransport and amiloride-sensitive Na channels
are present along the distal tubule [44—461. Now that the Na-Cl
cotransporter and Na channel have been cloned [47, 48], it is
evident from in situ hybridization studies that both thiazide and
amiloride-sensitive transporters are present along the length of
the rat distal convoluted tubule [47, 49]. This also appears to be
true for the mouse distal convoluted tubule [361. There is a
gradual transition of morphological changes of the distal convo-
luted tubule into the connecting tubule in the rat and mouse, but
a sharp change in the rabbit [50, 51]. The Na-Cl cotransporter is
confined to the DCT in the rat but extends into the connecting
tubule in the human kidney [491. The amiloride-sensitivc Na
channel is localized to the DCT and beyond into the connecting
and collecting tubule in the rat [47]. Accordingly, there may be
significant differences among the various species used in experi-
mentation. There may also be some heterogeneity in magnesium
transport along the distal tubule including the convoluted seg-
ments and the connecting tubule. Magnesium transport in the
connecting tubule has not been described to date.
Immortalized distal convoluted tubule cells were prepared by
Pizzonia et al from primary cultures of mouse cortical thick
ascending limb and distal convoluted tubule cells isolated by a
double antibody isolation technique [35]. This MDCT cell line
exhibits many of the characteristics of the distal convoluted tubule
[reviewed in 36]. Among these characteristics include inhibition of
Na-Cl cotransport and stimulation of Ca2 uptake by chiorothi-
azide [36, 52]. We have shown that MDCT cells absorb Mg2 in
a selective and concentration-dependent manner [34]. Accord-
ingly, this cell line may be useful to determine the effects of
chlorothiazide on Mg2 uptake. The MDCT cells are a trans-
formed line so that it may not be identical to the distal convoluted
tubule, in vivo, but its use may yield insights into Mg2 transport,
which may be applicable to the intact kidney.
Thiazides are extensively used in the management of congestive
heart failure and edema of hepatic or renal origin and the
treatment of hypertension, diabetes insipidus, and nephrolithiasis.
The natriuretic and anticalciuretic properties provide the basis for
its use in these diseases. Despite its widespread use, little is known
about the actions of thiazides on cellular magnesium transport.
Some studies have reported that patients receiving chlorothiazide
may develop magnesium deficiency, most likely, due to renal
magnesium-wasting [20—261. However, this is not a consistent
clinical finding as other studies have reported little effect of these
diuretics on renal magnesium conservation [13, 191. The data
presented here indicate that chlorothiazide acutely stimulates
Mg2 uptake in MDCT cells and cellular potassium depletion
diminishes Mg2 uptake. As chronic use of thiazides may be
associated with the occurrence of hypokalemia, we speculate that
thiazide-induced potassium depletion may be the basis for renal
magnesium-wasting and hypomagnesemia observed in some ther-
apeutic regimes.
Chlorothiazide increases Mg2 transport in MDCT cells
A number of experimental studies have suggested that acute
administration of chlorothiazide decreases urinary magnesium
excretion relative to the diuretic effects of increased sodium
excretion. Duarte acutely administered chlorothiazide (5 mg/kg)
to parathyroid-intact dogs undergoing a diuresis [141. Fractional
excretion of sodium (FENa) markedly increased from 1.3 to 7.9%
but the fractional excretion of magnesium (FEMg) remained
unchanged, 7.3%, following chlorothiazide administration. In
these studies, fractional calcium excretion (FEa) increased from
1.5 to 3.1%. Relative to the FEN, magnesium excretion fell
sixfold from 5.6 to 0.9 and calcium excretion decreased from 1.2 to
0.4 following chlorothiazide administration. Eknoyan and col-
leagues confirmed these studies and attributed the observation of
marked natriuresis and modest magnesiuria and calciuria to the
differential reabsorption of these cations in the loop and distal
tubule [15]. These studies suggest that chlorothiazide may in-
crease tubular reabsorption of magnesium relative to the natri-
uretic effects. We performed studies in thyroparathyroidecto-
mized dogs [16]. The acute administration of chlorothiazide
resulted in a relatively greater increase in fractional sodium
excretion (FENa) from 0,5 to 5.6% than calcium (FECa/FENa
increased from 1.3 to 1.9) or magnesium (FEMS/FENa fell from 1.4
to 1.3). Similar results were also observed in thyroparathyroidec-
tomized hamsters where FENa increased from 1.0 to 3.4% while
FEC.JFENa decreased from 22.7 to 5.0 and FEMS/FENa fell from
19.3 to 5.0 [17]. Micropuncture studies in the hamster indicated
that the actions of chlorothiazide occurred in the distal convo-
luted tubule [17]. Accordingly, the acute administration of chlo-
rothiazide produces a significant natriuresis together with little or
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no change in urinary calcium or magnesium excretion. The results
of these studies clearly demonstrate a divergence of sodium
absorption with calcium and magnesium transport within the
distal convoluted tubule.
In the present studies, we show that acute application of
chiorothiazide increases Mg2 influx by as much as 58% in an
established distal convoluted cell line. In a recent study, we have
shown that amiloride stimulates Mg2 transport in MDCT cells,
in part by hyperpolarizing the plasma membrane [34]. The notion
is that amiloride inhibits Na entry by blocking Na channels
leading to diminished intracellular Na concentration, which in
turn results in apical membrane hyperpolarization stimulating
Mg2 uptake. In support of this idea, it was shown that hyperpo-
larization by the application of the membrane-permanent SCN
or valinomycin, a potassium ionophore, stimulates Mg2 uptake
not unlike the actions of amiloride [34]. Chlorothiazide similarly
hyperpolarizes the apical membrane of the distal convoluted
tubule [39, 401 and MDCT cells used here [36]. Accordingly,
chiorothiazide may enhance Mg2 uptake by similar mechanisms
as those underlying amiloride stimulation of Mg2 transport.
These studies provide the cellular basis for the experimental
observations that show that acute administration of thiazides
enhance magnesium reabsorption and diminish urinary magne-
sium excretion relative to the changes observed for sodium.
The thiazide diuretics act principally in the distal convoluted
tubule to inhibit NaCl transport and increase calcium reabsorp-
tion [8, 11, 42, 53]. The mechanisms by which these agents alter
NaC1 and calcium transport are now reasonably clear. Thiazides
bind to the Na-Cl cotransporter in distal convoluted tubule cells,
thereby inhibiting electroneutral NaCl uptake across the apical
membrane with little or no effect on the transepithelial voltage
[43, 54]. This action leads to a rapid increase in urinary NaC1
excretion of about 2 to 5% of the filtered NaCl. Additionally,
inhibition of NaCl entry into distal convoluted tubule cells hyper-
polarizes the plasma membrane voltage [36, 39, 40], resulting in
enhanced calcium uptake across the luminal membrane through
calcium channels [42, 53]. Lajeunesse, Brunette and Mailoux
demonstrated that the hypocalcuric effect of thiazides is due to
increased calcium uptake across luminal membranes of distal
convoluted tubule cells [55]. Matsunaga et a! have shown that
hyperpolarization increases calcium uptake into MDCT cells, the
same cells that were used in the present study [56]. Chiorothiazide
increased calcium uptake, as measured with 45Ca, by 45 5%
over 12 minutes of study. They have further shown that chloro-
thiazide lead to hyperpolarization of the plasma membrane,
thereby enhancing hyperpolarization-activated calcium channels
and increasing the driving force for Ca2' entry into the distal
convoluted tubule cell [36]. The increase in calcium uptake
provides the cellular basis for the dissociation of sodium reab-
sorption and calcium transport in the distal tubule. The increase
in magnesium transport in the MDCT with thiazides is similar to
that which has been reported for thiazide-stimulation of calcium
reabsorption [11, 36, 42].
Cellular potassium depletion diminishes Mg2 uptake into
MDCT cells
Intracellular [K], determined with fluorescence, was 89 5
m in MDCT cells cultured in media containing 2.5 m potas-
sium for 18 hours. This represented a decrease in free [K]1 of 37
m or 29% of control cells. Using electron microprobe analysis,
Beck et al reported a decrease in total intracellular potassium,
32 3 mmol/kg wet wt, which represented a decrease of 21% in
total potassium in potassium depleted rat distal cells [57]. These
cells were obtained from rats fed potassium-deficient diets for 14
days and possessed plasma potassium concentrations of 2.0 0.1
m. Accordingly, culturing MDCT cells in media containing 2.5
m potassium leads to severe intracellular K depletion commen-
surate with values reported for cells in situ.
Cellular potassium depletion in MDCT cells results in dimin-
ished Mg2 uptake as determined by microfluorescence (Fig. 6).
The evidence suggests that the basis for this inhibition may be due
to depolarization of the plasma membrane of potassium depleted
MDCT cells. The evidence for this conclusion is twofold: first, the
transmembrane voltage of potassium depleted cells is significantly
depolarized compared to cells with normal K content. Mem-
brane depolarization decreases Mg2 uptake (Fig. 4). Second,
hyperpolarization with the application of the cell permanent
anion, SCN, enhanced Mg2 transport in potassium depleted
cells to a similar degree as that observed in normal cells (Fig. 5).
A depolarization in membrane voltage may provide an explana-
tion for diminished Mg2 uptake in potassium-depleted MDCT
cells. However, the degree of depolarization in potassium de-
pleted cells is modest and does not account for the 56% fall in
Mg2 uptake (Fig. 4). Accordingly, the diminished voltage ex-
plains only a part of the decrease in transport; other mechanisms
must be present to result in the marked decrease in Mg2
transport with potassium depletion.
The present studies indicate that cellular potassium depletion
may result in a depolarization in resting membrane potential in
MDCT cells. A change in intracellular [K] from 126 6 to 95
5 m is associated with a change in voltage from —65.5 2.0 to
—57.9 0.9 mV determined with the voltage-sensitive fluorescent
dye. The voltages were significantly different although they were
performed on different cells, that is, unpaired observations.
Depolarization of the membrane voltage is unexpected as exper-
imental potassium depletion has been shown to produce a decline
in [K]0 that is proportionately greater than in [K], and thus an
increase in voltage calculated from the Goldman constant-field
equation would be anticipated [58—61]. A number of studies have
shown that hypokalemia decreases membrane voltage in epithelial
and skeletal muscle cells. Using microelectrodes, Cemerikié,
Wilcox and Giebisch reported a hyperpolarization in membrane
potential of —7 mV in rat proximal tubule cells with a modest
decrease in intracellular K activity, 66 2 versus 58 3
mEq/liter with potassium depletion [58]. Khuri, Agulian and
Kalloghlian found that there was little change in the potential of
the distal convoluted tubule with a significant fall in [K], 47 2
versus 37 3 mat in potassium depleted rats [59]. Again using
microelectrodes, Bilbbey et a! have shown that the changes in
membrane potential of dog skeletal muscle with potassium defi-
ciency was biphasic [60]. In early deficiency the potential hyper-
polarized from —90 6 mV to —92 4 mV, whereas in late
deficiency the voltage depolarized to —55 5 mV, The intracel-
lular potassium concentrations iii the latter study were: control,
142 11; early potassium depletion, 120 16; and late potassium
depletion, 104 17 m. These results are consonant with those of
Kendig and Bunker in rat skeletal muscle cells [61]. Accordingly,
there are some discrepancies in the literature concerning the
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effect of potassium depletion on membrane voltage. These differ-
ences may be based on the duration of potassium depletion or on
other influences within intact potassium-depleted animals. The
present studies were performed on cultured MDCT cells rather
than distal convoluted cells in situ. Our results suggest that
potassium depletion may result in depolarization of the plasma
membrane.
Hypokalemia has been reported to be associated with an
increase in urinary magnesium and calcium excretion [27—30]. The
increase in urinary excretion of divalent cations may be explained
by the known effects of potassium depletion on the thick ascend-
ing limb of the loop [62]. Chloride conservation is impaired in
potassium-depleted rats, which may be related to altered basolat-
eral transport resulting in diminished NaC1 transport [63, 64]. To
date, there is no direct evidence for changes in magnesium and
calcium absorption in the thick ascending limb with potassium
depletion. However, as magnesium and calcium are absorbed by
passive mechanisms, dependent on NaCl transport, in this seg-
ment, it is probable that impaired NaCI transport may lead to
diminished divalent cation absorption [1, 65]. Although these
effects within the thick ascending limb may explain the effects of
hypokalemia on renal magnesium handling, it is apparent from
the present studies that potassium depletion may also have
important effects on magnesium transport within the distal con-
voluted tubule.
The interrelationship of magnesium and potassium metabolism
is an interesting one. A number of studies have reported a high
incidence of hypomagnesemia in patients with hypokalemia [26,
65, 66]. Whang, Oei and Hammiter state that the incidence of
hypomagnesemia in patients with hypokalemia may be as high as
42% [65]. Alfrey suggests that, under certain circumstances, the
disturbances may be a consequence of primary potassium deple-
tion with secondary magnesium depletion [67]. Notably, in all of
these patients potassium or magnesium replacement alone may
not be successful in correcting cell concentration without giving
both these cations together whether the deficiency resulted from
either primary magnesium or potassium depletion [65—67]. Al-
though clinically important, the cellular mechanisms of this inter-
relationship remain to be explained. The present studies were
performed in cells depleted of both magnesium and potassium;
accordingly, the present results should be interpreted with care.
Diminished uptake of Mg2 in potassium depletion may require
cellular depletion of both cations. Until an alternative method of
measuring magnesium transport is found, it is unknown whether
pure potassium depletion alters magnesium transport.
Chronic chiorothiazide may lead to renal magnesium-wasting
Chlorothiazide by inhibiting Na-Cl cotransport in the distal
convoluted tubule results in increased urinary NaCl excretion and
contraction of the extracellular fluid volume. The reduced vascu-
lar volume activates the renin-angiotensin system, elevating renin
and aldosterone levels. Elevated aldosterone levels lead to in-
creased sodium reabsorption through the apical membrane so-
dium channels and increased potassium and hydrogen ion secre-
tion that may result in hypokalemia and exacerbation of the
metabolic alkalosis. Volume depletion, elevated aldosterone, and
metabolic alkalosis increase renal magnesium conservation so that
it is unlikely that these influences would lead to magnesium-
wasting [68]. Since hypokalemia has been associated with altered
renal magnesium handling, it is postulated that chronic chiorothi-
azide use and cellular potassium depletion may inhibit magnesium
conservation, in part, in the distal convoluted tubule [27—30].
Interestingly, Gitelman's syndrome is also characterized by
renal magnesium-wasting and hypomagnesemia [69]. Gitelman's
syndrome represents a subset of Bartter's patients with hypokale-
mic alkalosis in conjunction with hypocalciuria and hypomag-
nesemia [69]. Some of the features of Gitelman's syndrome may
be observed in patients receiving thiazide diuretics, raising the
possibility that loss in Na-Cl cotransport could result in this
syndrome [70]. Recently, Simon et al used linkage and mutational
analysis to confirm that Gitelman's syndrome is indeed due to
mutations in the thiazide-sensitive Na-Cl cotransporter [70]. The
renal magnesium-wasting and hypomagnesemia in Gitelman's
patients remain to be explained. However, the present results
suggest that the basis of increased magnesium excretion may be
due to associated hypokalemia. If these suppositions are true then
it may be predicted that correction of the potassium deficits in
patients with Gitelman's may correct renal magnesium-wasting
independent of the genetic aberration of the Na-Cl cotransporter.
This remains to be determined.
In summary, the present results indicate that Mg2 uptake in
MDCT cells is stimulated by chlorothiazide. As chlorothiazide
hyperpolarizes the MDCT cell and hyperpolarization is associated
with enhanced Mg2 uptake, we speculate that the cellular effects
of chlorothiazide may be through changes in membrane voltage.
On the other hand, cellular K depletion leads to a diminished
Mg2 uptake. Cellular potassium depletion is associated with
membrane depolarization that decreases Mg2 uptake. Accord-
ingly, we conclude that potassium depletion may diminish Mg2
transport in MDCT cells. These observations suggest that chlo-
rothiazide-induced potassium depletion may have significant ef-
fects on Mg2 transport in the distal convoluted tubule leading to
renal magnesium-wasting. The association of hypomagnesiuria
with chronic chlorothiazide usage may be based, in part, on
concurrent intracellular potassium depletion in these patients.
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